A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
- Submitting institution
-
University of Oxford
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 12798
- Type
- D - Journal article
- DOI
-
10.1016/j.vaccine.2016.01.062
- Title of journal
- Vaccine
- Article number
- -
- First page
- 1412
- Volume
- 34
- Issue
- 11
- ISSN
- 0264-410X
- Open access status
- Out of scope for open access requirements
- Month of publication
- February
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
15
- Research group(s)
-
-
- Citation count
- 20
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to carrying out the study. The author helped draft the output.
- Non-English
- No
- English abstract
- -
